Trial Profile
Safety and efficacy of premixed insulin to insulin glargine plus oral antidiabetics in chinese patients with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2017
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 10 Oct 2017 New trial record